Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 25, 2021	Dec. 26, 2020
Operating Activities
Net income	$ 8,978	$ 7,679	$ 7,175
Depreciation and amortization	2,763	2,710	2,548
Gain associated with the Juice Transaction	(3,321)	0	0
Impairment and other charges	3,618	0	0
Operating lease right-of-use asset amortization	517	505	478
Share-based compensation expense	343	301	264
Restructuring and impairment charges	411	247	289
Cash payments for restructuring charges	(224)	(256)	(255)
Acquisition and divestiture-related charges	80	(4)	255
Cash payments for acquisition and divestiture-related charges	(46)	(176)	(131)
Pension and retiree medical plan expenses	419	123	408
Pension and retiree medical plan contributions	(384)	(785)	(562)
Deferred income taxes and other tax charges and credits	(873)	298	361
Tax expense related to the TCJ Act	86	190	0
Tax payments related to the TCJ Act	(309)	(309)	(78)
Change in assets and liabilities [Abstract]
Accounts and notes receivable	(1,763)	(651)	(420)
Inventories	(1,142)	(582)	(516)
Prepaid expenses and other current assets	118	159	26
Accounts payable and other current liabilities	1,842	1,762	766
Income taxes payable	57	30	(159)
Other, net	(359)	375	164
Net Cash Provided by Operating Activities	10,811	11,616	10,613
Investing Activities
Capital spending	(5,207)	(4,625)	(4,240)
Sales of property, plant and equipment	251	166	55
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets	(873)	(61)	(6,372)
Proceeds associated with the Juice Transaction	3,456	0	0
Other divestitures, sales of investments in noncontrolled affiliates and other assets	49	169	6
Short-term investments, by original maturity:
More than three months - purchases	(291)	0	(1,135)
More than three months - maturities	150	1,135	0
Three months or less, net	24	(58)	27
Other investing, net	11	5	40
Net Cash Used for Investing Activities	(2,430)	(3,269)	(11,619)
Financing Activities
Proceeds from issuances of long-term debt	3,377	4,122	13,809
Payments of long-term debt	(2,458)	(3,455)	(1,830)
Debt redemptions/cash tender offers	(1,716)	(4,844)	(1,100)
Short-term borrowings, by original maturity
More than three months - proceeds	1,969	8	4,077
More than three months - payments	(1,951)	(397)	(3,554)
Three months or less, net	(31)	434	(109)
Payments of acquisition-related contingent consideration	0	(773)	0
Cash dividends paid	(6,172)	(5,815)	(5,509)
Share repurchases - common	(1,500)	(106)	(2,000)
Proceeds from exercises of stock options	138	185	179
Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted	(107)	(92)	(96)
Other financing	(72)	(47)	(48)
Net Cash (Used for)/Provided by Financing Activities	(8,523)	(10,780)	3,819
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(465)	(114)	(129)
Net (Decrease)/Increase in Cash and Cash Equivalents and Restricted Cash	(607)	(2,547)	2,684
Cash and cash equivalents and restricted cash	$ 5,100	$ 5,707	$ 8,254